It's not easy to predict how the market will react to the results.
Key points will be reduction %, tolerance, efficacy, safety.
The only way to assess this is to compare it to Somavert.
Somavert earns pzifer 200mil a year, the product is expensive, a daily injected treatment, and has well documented side effects.
If ATL achieves similar % reduction but is safer and well tolerated, I'd expect ATL to become a the top shelf product as it only requires a weekly self administered injection and is predicted to be half the cost.
Expect positive data to fetch us a 50+ mil market cap, that's very fair. I also expect that if partnering hasn't happened within a very short period of the announcement, I believe a take over will undoubtably happen.
It all comes down to a magical % of IGF reductions. We were close prelim. Fingers crossed.
- Forums
- ASX - By Stock
- Neck on the chopping block
It's not easy to predict how the market will react to the...
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $74.82M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.2¢ | $9.57K | 112.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 11000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 0.081 |
4 | 62665 | 0.080 |
1 | 9500 | 0.078 |
1 | 30100 | 0.077 |
1 | 5000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 11000 | 1 |
0.090 | 105882 | 1 |
0.092 | 100000 | 1 |
0.093 | 46625 | 1 |
0.094 | 107837 | 1 |
Last trade - 15.56pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
8.2¢ |
  |
Change
0.002 ( 0.86 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.3¢ | 8.2¢ | 31700 | ||
Last updated 15.55pm 29/03/2024 ? |
Featured News
PER (ASX) Chart |